PSYENCE BIOMEDICAL LTD Cash And Cash Equivalents
PSYENCE BIOMEDICAL LTD (PBM) had Cash And Cash Equivalents of $7.15 million as of 2025-09-30, per its 6-K filed 2025-11-20.
Financial Statements › Notes
ifrs-full:CashAndCashEquivalents · last filed 2025-11-20
- 2023-03-31: Cash And Cash Equivalents 1.33M CAD.
CAD
| Period end | Cash And Cash Equivalents |
|---|---|
| 2023-03-31 | 1.33M CAD 6-K · filed 2025-01-23 |
USD
| Period end | Cash And Cash Equivalents |
|---|---|
| 2025-09-30 | $7.15M 6-K · filed 2025-11-20 |
| 2025-03-31 | $6.14M 6-K · filed 2025-11-20 |
| 2024-09-30 | $1.93M 6-K · filed 2025-11-20 |
| 2024-06-30 | $733.19K 6-K · filed 2025-01-23 |
| 2024-03-31 | $733.19K 6-K · filed 2025-11-20 |
| 2023-09-30 | $605.48K 6-K · filed 2025-01-23 |
| 2023-03-31 | $1.33M 20-F · filed 2025-06-25 |
| 2022-03-31 | $1.75M 20-F · filed 2025-06-25 |